Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 7th September 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Moredun Foundation awards two honorary fellowships
David Danson and David Smith were individually recognised for their outstanding contributions to the Moredun Group.

Veterinary professionals recognised for outstanding contributions

Two honorary fellowships were awarded to both David Danson and David Smith at the AGM of the Moredun Foundation, the governing body of Moredun Research Institute.

David Danson has spent most of his career in industry, working as director of global marketing for Mallinckrodt Animal Health Inc in Chicago, as well as managing director, then chairman of Biokema SA in Lausanne. Between 1998 and 2005, he was group chief executive of UA Group.

Mr Danson is currently a non-executive director of Eco Animal Health Group, a council member of the RVC and chairman of RVC Developments. He joined the board of Moredun Scientific in 2000, making significant contributions towards the growth of the company until his departure in 2019.

Dr David Smith has dedicated much of his career to understanding worm infections in sheep. He recently made a major breakthrough in the treatment of worm infections in livestock by successfully developing a vaccine for Haemonchus contortus, the most prevalent worm affecting sheep and goats globally.

Dr Smith is also a director of Wormvax Australia, the commercial company set up to produce and distribute the vaccine in Australia. Work is currently ongoing to expand distribution of the vaccine to other countries.

Speaking at the AGM on Thursday 3 September, Ian Duncan Millar, chairman of the Moredun Foundation said: “It is a huge honour to be able to recognise the contribution of people who really have made a difference. This year’s recipients have done just that in very different ways. David Danson by being a board member of Moredun Scientific during a period of considerable growth in business and reputation.

“In a very different way David Smith has dedicated his life to the understanding of sheep gut worms, and his achievement in producing and marketing the first vaccine against one of these parasites is truly worthy of recognition, and a wonderful example of the excellence of our Moredun science and scientists.”

Image (c) Moredun Foundation.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.